Literature DB >> 10688156

Defining the course of brain structural change and plasticity in schizophrenia.

L E DeLisi1.   

Abstract

Recent evidence from controlled CT and MRI longitudinal studies suggests that some cerebral ventricular enlargement and hemispheric volumetric reductions (e.g. cerebral atrophy) may have a progressive component in patients with schizophrenia. These studies vary in cohort composition, stage of illness examined, duration of follow-up interval, imaging techniques used, and specific brain regions with findings. They also conflict with earlier evidence suggesting that schizophrenia is a neurodevelopmental disorder with brain pathological deviance occurring prior to the illness onset. The newer brain imaging reports may be detecting subtle brain plasticity that results from a continuing cortical disruptive process, may be epi-phenomena caused by scanning and image analysis artifacts or may possibly reflect systemic physiological fluctuations. Future longitudinal studies of subjects at all stages of illness using a variety of new technologies are needed to clarify these findings.

Entities:  

Mesh:

Year:  1999        PMID: 10688156     DOI: 10.1016/s0925-4927(99)00033-5

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

Review 1.  The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia.

Authors:  Lynn E DeLisi
Journal:  Schizophr Bull       Date:  2008-02-08       Impact factor: 9.306

2.  Decreased axial diffusivity within language connections: a possible biomarker of schizophrenia risk.

Authors:  M Kubicki; M E Shenton; P K Maciejewski; P E Pelavin; K J Hawley; T Ballinger; T Swisher; G A Jabbar; H W Thermenos; M S Keshavan; L J Seidman; L E Delisi
Journal:  Schizophr Res       Date:  2013-06-22       Impact factor: 4.939

3.  What a Clinician Should Know About the Neurobiology of Schizophrenia: A Historical Perspective to Current Understanding.

Authors:  Lynn E DeLisi
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

4.  Early detection of schizophrenia by diffusion weighted imaging.

Authors:  Lynn E DeLisi; Kamila U Szulc; Hilary Bertisch; Magda Majcher; Kyle Brown; Arthika Bappal; Craig A Branch; Babak A Ardekani
Journal:  Psychiatry Res       Date:  2006-10-27       Impact factor: 3.222

Review 5.  What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia.

Authors:  Hilleke E Hulshoff Pol; René S Kahn
Journal:  Schizophr Bull       Date:  2008-02-17       Impact factor: 9.306

Review 6.  The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia.

Authors:  Joseph T Coyle; Guochuan Tsai
Journal:  Psychopharmacology (Berl)       Date:  2003-11-25       Impact factor: 4.530

Review 7.  The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?

Authors:  Lynn E DeLisi
Journal:  Curr Opin Psychiatry       Date:  2008-03       Impact factor: 4.741

Review 8.  Schizophrenia: solving the puzzle.

Authors:  B D Kelly; E O'Callaghan; A Lane; C Larkin
Journal:  Ir J Med Sci       Date:  2003 Jan-Mar       Impact factor: 1.568

Review 9.  Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia.

Authors:  Philip D Harvey; David A Loewenstein; Sara J Czaja
Journal:  Neurobiol Dis       Date:  2012-10-31       Impact factor: 5.996

10.  A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors.

Authors:  E Bramon; R M Murray
Journal:  Dialogues Clin Neurosci       Date:  2001-12       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.